Home » Topics » Regulatory

Regulatory
RSS

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Effexor XR cleared by FDA

Oct. 28, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...